1989
DOI: 10.1159/000248416
|View full text |Cite
|
Sign up to set email alerts
|

Studies on Two Siblings with Recessive Dystrophic Epidermolysis bullosa (Hallopeau-Siemens) and the Piasminogen Activator and Its Inhibitor in the Lesion

Abstract: Activities of piasminogen activators (PA) and their inhibitors were studied in the bullous lesions of 2 siblings with recessive dystrophic epidermolysis bullosa (RDEB). The hematological findings of the patients revealed hyperfibrinogenemia, hyper-γ-globulinemia and marked thrombocytosis. The immunofluorescent studies showed strong deposits of piasminogen, fibrin-degenerative products and α1-antitrypsin around the blister lesions. On the other hand, α1-macroglobulin (α2-M) was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1990
1990
2008
2008

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Increased activity of plasminogen activators, involved in the activation of MMPs, has been suggested to play a role in blister formation in RDEB patients [Kaneko et al, 1989]. The increased quantity of active MMP1 that we observed in the most affected patients could thus be due to a difference in the balance of activation/inhibition of plasmin by plasminogen activators (uPA, tPA) and by their inhibitors (PAIs).…”
Section: Discussionmentioning
confidence: 52%
“…Increased activity of plasminogen activators, involved in the activation of MMPs, has been suggested to play a role in blister formation in RDEB patients [Kaneko et al, 1989]. The increased quantity of active MMP1 that we observed in the most affected patients could thus be due to a difference in the balance of activation/inhibition of plasmin by plasminogen activators (uPA, tPA) and by their inhibitors (PAIs).…”
Section: Discussionmentioning
confidence: 52%
“…Their clinical phenotypes were as follows; three with dystrophic Hallopeau‐Siemens type (Patients 1–3), one with dystrophic non Hallopeau‐Siemens type (Patient 4), and the remaining one with non‐lethal junctional type without pyloric atresia (Patient 5). The details about Patients 2 and 4 have been reported previously (2, 7). Diagnoses were made on the basis of clinical, histological, and ultrastructural findings.…”
Section: To the Editormentioning
confidence: 99%